Local Immune Complex Disease

Slide 1 · Local Immune Complex Disease

Arthus reaction · localized type III hypersensitivity

From antigen deposition to necrotizing vasculitis

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define the Arthus reaction as a localized immune complex–mediated vasculitis.

Trace antigen exposure, immune complex formation, inflammation, necrosis, and thrombosis.

Connect neutrophils, complement, and fibrinoid necrosis to vessel-wall injury.

Distinguish localized Arthus injury from systemic immune complex disease and other mechanisms.

Slide 3 · The defining lesion

The Arthus reaction is acute, localized immune complex vasculitis.

The classic experimental site is the skin.

Vessel-wall injury can produce localized tissue necrosis.

A superimposed thrombus adds an ischemic component to injury.

Slide 4 · Local versus systemic immune complex disease

Local: Arthus reaction

Antigen is introduced into a limited tissue site.

Large complexes form locally in vascular walls.

Cutaneous vasculitis and tissue necrosis predominate.

Systemic: Serum sickness

Circulating complexes form after an antibody response.

Complexes deposit in vessels and susceptible organs.

Multi-organ manifestations can follow deposition.

Slide 5 · Necessary experimental components

Prior immunization

Host already has circulating antibody against the antigen.

Local antigen

Antigen is injected intracutaneously at one site.

Accessible vessels

Antigen can diffuse to local vascular walls.

Slide 6 · Arthus reaction: The source sequence

Previously immunized host

Intracutaneous antigen

Large local complexes

Necrotizing vasculitis

Local tissue injury

Thrombosis may superimpose on vessel damage and aggravate ischemia.

Slide 7 · Why prior immunization matters

The experimental host already contains circulating antibodies specific for the injected antigen.

Antibody is therefore present when antigen arrives at the vascular wall.

This permits a localized antigen–antibody reaction without first waiting for a new primary antibody response.

Slide 8 · Antigen and antibody begin in different locations

Locally introduced antigen

Antigen enters the skin at the injection site.

It diffuses outward toward local blood vessels.

Its spatial distribution helps localize the lesion.

Preformed specific antibody

Specific antibody is already present in blood.

It encounters antigen as antigen reaches vessel walls.

Binding creates immune complexes in situ.

Slide 9 · The local microvascular setting

Vessel lumen

Vessel wall

Antigen reaches the wall of a local blood vessel, where specific antibody is available.

Schematic (not histology)

Slide 10 · Antigen diffusion creates a focal reaction

Antigen placed in skin

Movement toward vessel

Encounter with antibody

Local complex formation

The location of the antigen–antibody encounter explains the localized tissue distribution.

Slide 11 · Where immune complexes form

The Arthus model emphasizes formation of large immune complexes locally in vessel walls.

This is an example of immune complexes formed at a tissue site, rather than only in the circulation.

The shared pathologic endpoint of type III reactions is inflammation wherever complexes deposit.

Slide 12 · Large complexes form near the vessel wall

Vessel lumen

Vessel wall

Blue antigen and purple antibody symbols illustrate binding; The diagram is conceptual.

Schematic (not histology)

Slide 13 · Complexes deposit within vascular walls

Vessel lumen

Vessel wall

Deposited immune complexes convert an antigen–antibody reaction into a vessel-wall lesion.

Schematic (not histology)

Slide 14 · Immune complex formation is not yet tissue necrosis

Immunologic event

Antigen binds specific antibody.

Large antigen–antibody complexes form.

Complexes become localized in the vessel wall.

Pathologic consequence

Deposited complexes initiate acute inflammation.

Inflammatory cells injure the vessel wall.

Fibrinoid necrosis and thrombosis may result.

Slide 15 · Type III hypersensitivity as the mechanism

Antigen–IgG complexes damage tissues mainly through inflammation at sites of deposition.

Complexes may arise in the circulation or locally in tissues.

Antigens may be foreign proteins, microbial products, or self antigens.

Distribution of deposits influences the clinical pattern of injury.

Slide 16 · Deposited complexes activate an inflammatory cascade

Immune complex deposition

Complement activation

Leukocyte recruitment

Leukocyte activation

Vascular injury

Complement and Fc receptor engagement amplify the inflammatory response.

Slide 17 · Three linked effector processes

Complement

C3a and C5a increase vascular permeability.

C5a is chemotactic.

Cell recruitment

Granulocytes and monocytes migrate to sites of deposits.

Neutrophils dominate acute vasculitis.

Tissue injury

Leukocytes release proteases and reactive oxygen species.

Structural vessel elements are damaged.

Slide 18 · Complement connects deposits to vessel injury

Immune complexes activate complement at the site of deposition.

C5a contributes chemotactic signals that recruit inflammatory leukocytes.

C3a and C5a contribute to increased vascular permeability, supporting local inflammation.

Slide 19 · C5a drives leukocyte recruitment

Complexes activate complement

C5a generated

Neutrophils migrate

Acute vascular inflammation

Chemotaxis explains why immune complex–injured vessel walls become neutrophil-rich.

Slide 20 · Chemotaxis and activation are distinct steps

Recruitment

C5a directs leukocyte migration toward deposited complexes.

Inflammatory cells accumulate near injured vessels.

Activation

Leukocyte Fc and complement receptors engage immune material.

Activated cells release enzymes and reactive oxygen intermediates.

Slide 21 · Leukocyte receptors in antibody-mediated inflammation

Fc receptors

Recognize the Fc region of deposited IgG.

Help activate recruited leukocytes.

Complement receptors

Recognize complement fragments such as C3b.

Provide additional activation signals.

Slide 22 · How proteases damage vascular tissue

Activated leukocytes release lysosomal enzymes including proteases.

Proteases can digest basement membrane, collagen, and elastin.

This is a mechanism of structural vessel-wall destruction, rather than merely antibody binding.

Slide 23 · Reactive oxygen species add to injury

Activated leukocytes generate reactive oxygen species.

These reactive intermediates contribute to damage at sites of antibody-mediated inflammation.

In the Arthus reaction, this inflammation is spatially concentrated around deposited complexes.

Slide 24 · Neutrophilic inflammation surrounds the vessel

Vessel lumen

Vessel wall

N

N

N

N

N

N

N = recruited neutrophils; The diagram denotes immune-complex–associated vessel injury.

Schematic (not histology)

Slide 25 · From inflammation to fibrinoid necrosis

Deposited complexes

Acute vasculitis

Vessel wall destruction

Fibrinoid necrosis

The pathologic endpoint is necrosis of the vessel wall with intense inflammation.

Slide 26 · The central histologic pattern

Acute vasculitis with neutrophilic infiltration and vessel-wall necrosis.

Neutrophils are a major component of the acute inflammatory infiltrate.

Necrosis is located in the affected vessel wall.

Fibrinoid material appears as smudgy eosinophilic tissue destruction on routine microscopy.

Slide 27 · Vasculitis: Cellular and structural components

Inflammatory component

Intense neutrophilic infiltration.

Complement-mediated recruitment.

Leukocyte activation and enzyme release.

Wall injury component

Necrosis of affected vascular wall.

Fibrinoid appearance of damaged tissue.

Potential superimposed thrombosis.

Slide 28 · Fibrinoid necrosis: Why it looks eosinophilic

The necrotic vessel wall contains material from damaged tissue and deposited plasma constituents.

Immune complexes, complement, and plasma proteins contribute to the eosinophilic appearance.

This produces a smudgy zone of tissue destruction described as fibrinoid necrosis.

Slide 29 · Components of the fibrinoid zone

Necrotic wall

Destruction of vascular tissue underlies the change.

Immune material

Immune complexes and complement occur at sites of injury.

Plasma proteins

Extravasated plasma constituents add to eosinophilic material.

Slide 30 · Wall necrosis and the lumen are linked

Vessel lumen

Vessel wall

N

N

N

N

N

N

The vascular wall is the target of injury; Luminal obstruction can become a second insult.

Schematic (not histology)

Slide 31 · Thrombosis aggravates ischemic injury

Thrombus formation is not the initiating antigen–antibody event.

Vessel-wall necrosis follows local immune complex–associated vasculitis.

Superimposed thrombosis compromises the damaged vessel further.

Ischemic injury is intensified when thrombosis develops.

Slide 32 · Thrombosis superimposed on vasculitis

Vessel lumen

Vessel wall

N

N

N

N

N

N

Thrombus

Worsened ischemic injury

The model separates vessel-wall inflammation from additional luminal thrombosis.

Schematic (not histology)

Slide 33 · Why tissue necrosis becomes pronounced

Immune complex vasculitis

Vessel-wall necrosis

Superimposed thrombosis

Worsened ischemia

Two connected processes—wall destruction and impaired perfusion—compound local tissue injury.

Slide 34 · Identify two forms of damage

Direct inflammatory injury

Complement and leukocytes injure the vessel wall.

Fibrinoid necrosis is the characteristic morphologic pattern.

Secondary ischemic injury

Thrombosis is superimposed on necrotizing vasculitis.

Reduced tissue perfusion worsens local damage.

Slide 35 · From microscopic observation to mechanism

Microscopic finding

Supported inference

Mechanistic link

Neutrophils in vessel wall

Acute inflammation

Complement recruitment

Necrotic vessel wall

Vasculitic injury

Leukocyte mediators

Smudgy eosinophilic material

Fibrinoid necrosis

Necrotic tissue + deposits

Luminal thrombus

Secondary ischemic component

Superimposed thrombosis

Slide 36 · In situ and circulating immune complexes

In situ complex formation

Antigen is present or becomes established at a tissue site.

Antibody binds antigen locally.

The Arthus model illustrates localized vascular deposition.

Circulating complexes

Antigen and antibody combine within the blood.

Complexes subsequently deposit at susceptible sites.

Serum sickness provides the systemic prototype.

Slide 37 · Arthus reaction versus serum sickness

Feature

Arthus reaction

Serum sickness

Antibody condition

Preformed specific antibody

Antibody response after systemic antigen

Complex generation

Localized at vascular walls

Initially in circulation

Distribution

Focal, commonly skin

Systemic; vessels and organs

Pathologic focus

Acute cutaneous vasculitis

Vasculitis and organ injury

Slide 38 · Why immune complex distribution matters

The site at which antigen and antibody meet influences the initial location of complexes.

Deposited complexes induce inflammation in their immediate tissue environment.

This explains how the same type III effector mechanism can have focal or systemic expression.

Slide 39 · Sites often affected in systemic disease

Glomeruli

High-pressure filtration helps concentrate complexes.

Nephritis can result.

Joints

Complex deposition can involve synovial sites.

Arthritis may result.

Small vessels

Deposits initiate acute vessel-wall inflammation.

Vasculitis may result.

Slide 40 · Other examples contextualize type III injury

Immune complex disorder

Antigen listed by Robbins

Manifestation

Systemic lupus erythematosus

Nuclear antigens

Nephritis, skin lesions, arthritis

Poststreptococcal GN

Streptococcal antigens

Nephritis

Polyarteritis nodosa

HBV antigens in some cases

Systemic vasculitis

Reactive arthritis

Bacterial antigens (e.g., Yersinia)

Acute arthritis

Slide 41 · What antigen identity does—and does not—tell us

Antigen identity

Foreign injected proteins can drive experimental Arthus lesions.

Type III disorders may also involve microbial or self antigens.

Anatomic distribution

Deposition determines the inflamed tissue.

A focal skin lesion differs from glomerular or systemic vasculitis.

Slide 42 · Type II versus type III antibody-mediated injury

Feature

Type II

Type III

Antigen location

Fixed cell or matrix target

Soluble or tissue-planted antigen

Antibody pattern

Binds pre-existing target

Forms antigen–antibody complexes

Injury examples

Opsonization, inflammation, dysfunction

Inflammation at deposit sites

Illustration

Basement membrane antibody reaction

Arthus localized vasculitis

Slide 43 · A tissue contains IgG deposits: Is every antibody lesion type III?

Does antibody-related inflammation automatically prove immune complex disease?

Mechanism

No. Type II and type III can both involve antibodies and complement.

Reasoning

The key distinction is antibody binding to fixed targets versus complexes formed with antigen.

Slide 44 · Type III versus type IV hypersensitivity

Dimension

Type III (Arthus)

Type IV (T-cell mediated)

Key mediator

Antigen–antibody complexes

T-cell cytokines / cytotoxicity

Initiating context

Complex deposition in tissue

Antigen-recognizing T lymphocytes

Principal injury

Complement and leukocyte inflammation

T-cell–driven inflammation or killing

Teaching prototype

Arthus reaction

Delayed-type hypersensitivity

Slide 45 · Avoid conflating Type III and Type IV

An antigen challenge in skin can lead to mechanistically different reactions.

Arthus: Preexisting antibodies + vascular immune complexes + acute vasculitis.

T-cell–mediated hypersensitivity: Cytokines from T cells drive tissue inflammation.

The site of exposure alone does not classify the hypersensitivity mechanism.

Slide 46 · What morphology can establish

Acute vasculitis can be recognized through inflammatory injury to the vessel wall.

Neutrophilic inflammation and fibrinoid necrosis support an acute necrotizing pattern.

Morphology should be connected to the antigen–antibody mechanism; A pattern alone does not identify a specific inciting antigen.

Slide 47 · Immune deposits across organs: Avoid overgeneralization

Renal example

Immunofluorescence may show granular immunoglobulin and complement deposits.

Electron microscopy may show electron-dense deposits along the GBM.

Arthus skin model

The provided passage specifies necrotizing cutaneous vasculitis.

It does not state a specific skin IF/EM pattern or diagnostic threshold.

Slide 48 · How would you interpret fibrinoid necrosis?

Is fibrinoid necrosis equivalent to a unique proof of an Arthus reaction?

Mechanism

No. Fibrinoid necrosis as a principal morphology of immune complex vascular injury.

Reasoning

Interpret tissue pattern alongside local antigen exposure and preexisting antibody.

Slide 49 · What the supplied Robbins passage does not quantify

It provides no numerical diagnostic threshold for the local Arthus reaction.

It does not supply a validated clinical grading system or sensitivity/specificity data.

It does not document a particular time-to-onset or standardized treatment protocol for human cutaneous Arthus reactions.

Slide 50 · Mechanism exercise: Previously immunized host

A previously immunized animal receives intracutaneous antigen. What must occur before vasculitis?

Mechanism

Specific antibody binds the introduced antigen and large immune complexes form locally in vessel walls.

Reasoning

This is the initiating local immunologic event in the Robbins Arthus model.

Slide 51 · Mechanism exercise: Complement activation

Why does a vessel containing immune complexes attract neutrophils?

Mechanism

Deposited complexes trigger complement; C5a recruits leukocytes to the inflamed vascular site.

Reasoning

The accumulated neutrophils contribute to acute vasculitic injury.

Slide 52 · Mechanism exercise: Destroyed wall

Which processes explain fibrinoid necrosis rather than mere immune deposition?

Mechanism

Leukocyte activation and release of enzymes and reactive oxygen intermediates damage the vessel wall.

Reasoning

Deposited complexes initiate injury but are not the entire pathologic event.

Slide 53 · Mechanism exercise: Deteriorating ischemia

A localized necrotizing vasculitis develops luminal thrombosis. Why is injury amplified?

Mechanism

The thrombus adds impaired perfusion to preexisting inflammatory vessel-wall destruction.

Reasoning

Robbins explicitly identifies superimposed thrombosis as a factor worsening ischemia.

Slide 54 · Five findings in a mechanistic chain

Observation / context

Pathologic meaning

Place in sequence

Prior antigen sensitization

Specific circulating antibody

Prerequisite

Local antigen introduction

Antigen diffuses into vascular wall

Trigger

Deposited large complexes

Local antigen–antibody interaction

Immune phase

Neutrophilic necrotizing vasculitis

Inflammatory vessel damage

Effector phase

Associated thrombosis

Additional reduction of perfusion

Amplifier

Slide 55 · Reconstruct the entire Arthus lesion

Specific antibody already present

Antigen enters vessel wall

Large complexes deposit

Acute neutrophilic vasculitis

Necrosis ± thrombus

Anatomic concentration of complexes explains localization; Effector injury explains pathology.

Slide 56 · Core clinicopathologic synthesis

Focal immune complex formation drives focal vascular inflammation.

Trigger: Local antigen challenge in an immunized host.

Mechanism: Antibody complexes, complement, and recruited leukocytes.

Morphology: Acute necrotizing vasculitis with fibrinoid change.

Amplification: Thrombosis worsens ischemic tissue injury.

Slide 57 · Interpretation pitfalls to avoid

Do not assume

Every antibody-associated vasculitis is Arthus.

Fibrinoid necrosis alone identifies the antigen.

The renal granular IF description directly applies to skin.

Instead establish

Evidence for a local antigen–antibody reaction.

Relationship of complex deposition to inflammation.

Specific morphology and anatomic distribution.

Slide 58 · High-yield distinctions

Question

Best source-grounded answer

What makes it local?

Complexes form at the local antigen-exposure site.

What injures the wall?

Complement-driven, neutrophil-rich inflammation.

Why eosinophilic necrosis?

Necrotic tissue with complex, complement, and plasma protein.

Why ischemia worsens?

Superimposed thrombosis.

What is the systemic analog?

Serum sickness with circulating complexes.

Slide 59 · Reference and scope

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).

Topic section: Local Immune Complex Disease; contextual mechanisms from Type III hypersensitivity and antibody-mediated inflammation.

Morphology context: immune complex–associated vasculitis and fibrinoid necrosis.

All diagrams in this lecture are original, editable schematics—not clinical or histopathologic specimens.